JATT Acquisition Corp Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant

YTD

ALL

Why Robinhood?

You can watch JATT= and buy or sell other stocks, ETFs, and their options commission-free!

About JATT=

Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases.

CEO

Robert Lisicki

CEORobert Lisicki

Employees

Employees30

Headquarters

Henderson, Nevada

HeadquartersHenderson, Nevada

Founded

2022

Founded2022

Employees

Employees30

JATT= Key Statistics

Market cap

587.68M

Market cap587.68M

Price-Earnings ratio

42.02

Price-Earnings ratio42.02

Dividend yield

—

Dividend yield—

Average volume

1.64K

Average volume1.64K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$10.90

52 Week high$10.90

52 Week low

$9.00

52 Week low$9.00

JATT Acquisition Corp Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant

Why Robinhood?

Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. Show more

JATT= Key Statistics

Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases.